Pancreatic hypoplasia-diabetes-congenital heart disease syndrome
Learn about Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, its reported features, relevant specialists, and questions to discuss at a medical
Also known as: PACHD; Pancreatic agenesis and congenital heart defects syndrome; Yorifuji-Okuno syndrome
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.
What it is
From: Orphanet
A rare, syndromic diabetes mellitus characterized by partial pancreatic agenesis, diabetes mellitus, and heart anomalies (including transposition of the great vessels, ventricular or atrial septal defects, pulmonary stenosis, or patent ductus arteriosis).
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Atrial septal defect · Very frequent (99-80%)
- Atrial septal defect (ASD) is a congenital abnormality of the interatrial septum that enables blood flow between the left and right atria via the interatrial septum.
- Exocrine pancreatic insufficiency · Very frequent (99-80%)
- Impaired function of the exocrine pancreas associated with a reduced ability to digest foods because of lack of digestive enzymes.
- Patent foramen ovale · Very frequent (99-80%)
- Failure of the foramen ovale to seal postnatally, leaving a potential conduit between the left and right cardiac atria.
- Ventricular septal defect · Very frequent (99-80%)
- A hole between the two bottom chambers (ventricles) of the heart. The defect is centered around the most superior aspect of the ventricular septum.
- Neonatal insulin-dependent diabetes mellitus · Very frequent (99-80%)
- Failure to thrive · Frequent (79-30%)
- Failure to thrive (FTT) refers to a child whose physical growth is substantially below the norm.
- Feeding difficulties · Frequent (79-30%)
- Impaired ability to eat related to problems gathering food and getting ready to suck, chew, or swallow it.
- Intellectual disability · Frequent (79-30%)
- The term intellectual disability or intellectual developmental disorder is used to describe significantly sub-average intellectual and adaptive functioning based on clinical assessment and as measured by individually administered, appropriately normed, standardized and validated tests of intellectual functioning and adaptive behavior, with onset during the developmental period from infancy through adolescence.
- Intermittent diarrhea · Frequent (79-30%)
- Repeated episodes of diarrhea separated by periods without diarrhea.
- Intrauterine growth retardation · Frequent (79-30%)
- An abnormal restriction of fetal growth with fetal weight below the tenth percentile for gestational age.
- Pancreatic aplasia · Frequent (79-30%)
- Aplasia of the pancreas.
- Pancreatic hypoplasia · Frequent (79-30%)
- Hypoplasia of the pancreas.
- Small for gestational age · Frequent (79-30%)
- Smaller than normal size according to sex and gestational age related norms, defined as a weight below the 10th percentile for the gestational age.
- Hernia · Frequent (79-30%)
Other findings in the same source
From: Orphanet
Additional reported features include Congenital hypothyroidism (Occasional (29-5%)); Double outlet left ventricle (Occasional (29-5%)); Hypoplasia of right ventricle (Occasional (29-5%)); Hypoplastic tricuspid valve (Occasional (29-5%)); Neonatal hypotonia (Occasional (29-5%)); Oligohydramnios (Occasional (29-5%)); Patent ductus arteriosus (Occasional (29-5%)); Prolonged partial thromboplastin time (Occasional (29-5%)); Pulmonary artery stenosis (Occasional (29-5%)); Pulmonic stenosis (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
All ages
Inheritance in the source
From: Orphanet
Autosomal dominant
Frequency and the population described
From: Orphanet
Reported case(s): 10.0; Worldwide. This is a published case count, not prevalence. Point prevalence: <1 / 1 000 000; Worldwide; Class only.
Understanding the inheritance label
From: MedlinePlus Genetics
An autosomal dominant pattern means that one altered copy of a relevant gene can be sufficient for the condition. Some affected people inherit the change; others have a new change without an affected parent. The precise finding, family history and condition determine what this means for relatives.
Which doctor should you see?
The suggested department for discussing Pancreatic hypoplasia-diabetes-congenital heart disease syndrome is Endocrinology, with a endocrinologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Which hormone or metabolic finding is important in this case?
- How should test timing and current medicines be taken into account?
- What follow-up would show whether the care plan is working?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Pancreatic hypoplasia-diabetes-congenital heart disease syndrome. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by an endocrinologist. Every profile shows the doctor’s registration and what has been checked.
All endocrinology conditions →
Sources
- Orphanet — Pancreatic hypoplasia-diabetes-congenital heart disease syndrome — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- MedlinePlus Genetics — inheritance patterns — Public-domain Genetics education
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1796.